Skip to main content

Florida Bill: SB 688

Florida Naturopathic Medicine Licensure and Regulation

Topics

Health Freedom

Bill Information

MAHA Approved

Summary

Bill Summary

Florida Senate Bill 688 establishes a comprehensive regulatory framework for naturopathic medicine in Florida by creating a Board of Naturopathic Medicine within the Department of Health, defining licensure requirements through examination and endorsement, and setting standards for continuing education and professional conduct. The bill expands the definition of telehealth providers to include licensed naturopathic doctors, allowing them to offer services remotely, and clarifies that unlicensed individuals may practice traditional naturopathy without misrepresenting themselves as licensed practitioners. It also establishes disciplinary procedures, license renewal requirements, and reactivation provisions for naturopathic doctors while making conforming amendments to related Florida Statutes with an effective date of December 31, 2026.

Why It Matters to MAHA

This bill directly advances health freedom and patient autonomy by formally recognizing naturopathic medicine as a legitimate healthcare discipline and creating a pathway for qualified practitioners to become licensed professionals. MAHA supports measures that expand access to innovative and alternative treatment modalities that patients choose, and this bill removes barriers by allowing naturopathic doctors to practice and provide telehealth services alongside conventional healthcare providers. The regulatory framework ensures transparency and safety through professional standards and continuing education requirements while respecting the ability of individuals to pursue natural health practices without licensing if they do not claim professional credentials. By establishing clear licensure standards and a dedicated board, the bill protects patients from fraud while empowering those who prefer naturopathic approaches to access qualified practitioners, embodying MAHA's commitment to reducing regulatory barriers that unnecessarily limit patient choice and access to diverse treatment options.

Introduced

03/10/2026

In Committee

03/10/2026

Passed

03/11/2026

Sponsors

Fiscal Policy

Primary Primary

Ana Maria Rodriguez

Ana Maria Rodriguez

Republican Senator (FL)

Activity

12/01/2025

Filed

12/16/2025

Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy

01/13/2026

Introduced

02/06/2026

On Committee agenda-- Health Policy, 02/11/26, 3:00 pm, 412 Knott Building

02/11/2026

Favorable by Health Policy; YEAS 8 NAYS 3

02/12/2026

Now in Appropriations Committee on Health and Human Services

02/20/2026

On Committee agenda-- Appropriations Committee on Health and Human Services, 02/25/26, 10:00 am, 412 Knott Building

02/25/2026

Favorable by Appropriations Committee on Health and Human Services; YEAS 5 NAYS 1

02/25/2026

Now in Fiscal Policy

02/25/2026

On Committee agenda-- Fiscal Policy, 03/02/26, 12:00 pm, 412 Knott Building

03/02/2026

CS by- Fiscal Policy; YEAS 18 NAYS 0

03/03/2026

Pending reference review -under Rule 4.7(2) - (Committee Substitute)

03/03/2026

CS by Fiscal Policy read 1st time

03/04/2026

Placed on Calendar, on 2nd reading

03/04/2026

Placed on Special Order Calendar, 03/05/26

03/05/2026

Read 2nd time

03/05/2026

Read 3rd time

03/05/2026

CS passed; YEAS 33 NAYS 3

03/05/2026

In Messages

03/10/2026

Bill referred to House Calendar

03/10/2026

Bill added to Special Order Calendar (3/11/2026)

03/10/2026

1st Reading (Committee Substitute 1)

03/11/2026

Read 2nd time

03/11/2026

Added to Third Reading Calendar

03/11/2026

Read 3rd time

03/11/2026

CS passed; YEAS 85, NAYS 22

03/17/2026

Ordered enrolled

Questions or suggestions?

Have questions about this bill or our legislative tracker? We'd love to hear from you. Contact us and we'll get back to you as soon as possible.